GlassScriptPhysician profile
Marion Buckwalter
NPI 1356394589
$20,484.15
in general payments reported to CMS, 2019-2025
2 companies · $42.94 in 2025
The $42.94 reported for 2025 was less than what a typical Neurocritical Care provider received nationally (typical 2025 total: $95.82).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $20K · 2025: $42.94.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $10K · Travel and Lodging: $9,987 · Food and Beverage: $149.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $10,347.50 |
| Travel and Lodging | $9,987.23 |
| Food and Beverage | $149.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| F. Hoffmann-La Roche Ag | $20,441.21 | 2024 | |
| Emd Serono Research & Development Institute, INC. | $42.94 | 2025 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marion Buckwalter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.